PMXSF (Syntara) Other Current Liabilities: $0.30 Mil (As of Dec. 2025)


PMXSF Syntara Ltd PMXSF
13 GF Score
Price $0.03
! 1 Warning Sign
View Full Analysis

What is Syntara Other Current Liabilities?

Syntara PMXSF 13 Other Current Liabilities is $0.30 Mil as of Dec. 2025. GuruFocus rates PMXSF with a GF Score™ of 13/100. The stock has 1 warning sign investors should review.

Syntara's other current liabilities for the quarter that ended in Dec. 2025 was $0.30 Mil.

Syntara's quarterly other current liabilities increased from Dec. 2024 ($0.27 Mil) to Jun. 2025 ($0.29 Mil) and increased from Jun. 2025 ($0.29 Mil) to Dec. 2025 ($0.30 Mil).

Syntara's annual other current liabilities declined from Jun. 2023 ($0.85 Mil) to Jun. 2024 ($0.65 Mil) and declined from Jun. 2024 ($0.65 Mil) to Jun. 2025 ($0.29 Mil).


Syntara Other Current Liabilities Related Terms


Syntara Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Syntara's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Syntara Other Current Liabilities Chart

Syntara Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.60 0.96 0.85 0.65 0.29

Syntara Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.82 0.65 0.27 0.29 0.30
PMXSF
13GF Score
Syntara Ltd PMXSF
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Syntara Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $0.30 Mil mean?
Syntara (PMXSF) has a Other Current Liabilities of $0.30 Mil as of Dec. 2025. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Syntara.
Is Syntara's Other Current Liabilities too high?
Syntara's current Other Current Liabilities is $0.30 Mil. Overall, Syntara has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Syntara's Other Current Liabilities compare to ZTS and UTHR?
Syntara's Other Current Liabilities of $0.30 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Drug Manufacturers company?
A good Other Current Liabilities depends on the Drug Manufacturers industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Syntara. Syntara's current Other Current Liabilities is $0.30 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Syntara stock overvalued right now?
Syntara (PMXSF) has a current Other Current Liabilities of $0.30 Mil. The current Other Current Liabilities is $0.30 Mil. Syntara's overall GF Score™ is 13/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Syntara (PMXSF), the current Other Current Liabilities is $0.30 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Syntara Business Description

Other Exchanges UUDA:GermanySNT:Australia
Address 20 Rodborough Road, Unit 2, Frenchs Forest, Sydney, NSW, AUS, 2086
Syntara Ltd is a clinical-stage drug development company working to bring new and life-changing treatments to patients in need. It is targeting extracellular matrix dysfunction with its expertise in amine oxidase chemistry and other technologies to develop novel medicines for blood cancers and conditions linked to inflammation and fibrosis. The company has various drug candidates in its pipeline such as SNT-5505, SNT-4728, SNT-5382, and SNT-8370 as a potential treatment for cancer, skin scarring and neuroinflammation.
13GF Score

Get the complete analysis for PMXSF

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.03
Price